Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: Data from the randomized, double-blind, COMBO-DN study

Pain

Volumn 155, Issue 10, 2014, Pages 2171-2179

  Bouhassira, Didier ^a   Wilhelm, Stefan ^b   Schacht, Alexander ^b   Perrot, Serge ^c   Kosek, Eva ^d   Cruccu, Giorgio ^e   Freynhagen, Rainer ^f   Tesfaye, Solomon ^g   Lledó, Alberto ^h   Choy, Ernest ⁱ   Marchettini, Paolo ^j,n   Micó, Juan Antonio ^k   Spaeth, Michael ^l   Skljarevski, Vladimir ^m   Tölle, Thomas ^f  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LILLY DEUTSCHLAND GMBH   (Germany)

^c HÔTEL DIEU   (France)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^h Clinica Creu Blanca   (Spain)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

^j SAN RAFFAELE HOSPITAL   (Italy)

^k UNIVERSITY OF CÁDIZ   (Spain)

^l Memory Clinic   (Switzerland)

^m ELI LILLY AND COMPANY   (United States)

ⁿ UNIVERSITY OF APPLIED SCIENCES AND ARTS OF SOUTHERN SWITZERLAND   (Switzerland)

more..

Author keywords

Diabetic neuropathy; Duloxetine; Neuropathic Pain Symptom Inventory; Pregabalin; Sensory symptoms; Stratified treatment

Indexed keywords

DULOXETINE; PREGABALIN; ANALGESIC AGENT;

ADD ON THERAPY; ADULT; AGED; ARTICLE; BRIEF PAIN INVENTORY; CLINICAL TRIAL; DIABETIC NEUROPATHY; DRUG MEGADOSE; DYSESTHESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPATHIC PAIN; NEUROPATHIC PAIN SYMPTOM INVENTORY; PAIN SEVERITY; PARESTHESIA; PHENOTYPE; POST HOC ANALYSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; TREATMENT RESPONSE; COMPLICATION; CONTROLLED STUDY; DIABETIC NEUROPATHIES; DOUBLE BLIND PROCEDURE; MIDDLE AGED; NEURALGIA; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALGESICS; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; DULOXETINE HYDROCHLORIDE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA; PREGABALIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84908110150     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2014.08.020     Document Type: Article

References (29)

1. C.A. Abbott, R.A. Malik, E.R.E. van Ross, J. Kulkarni, and A.J.M. Boulton Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 34 2011 2220 2224
2. N. Attal, D. Bouhassira, R. Baron, J. Dostrovsky, R.H. Dworkin, N. Finnerup, G. Gourlay, M. Haanpää, S. Raja, A.S.C. Rice, D. Simpson, and R.D. Treede Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome? Eur J Pain 15 2011 441 443
3. N. Attal, V. Gaudé, L. Brasseur, M. Dupuy, F. Guirimand, F. Parker, and D. Bouhassira Intravenous lidocaine in central pain: a double-blind, placebo-controlled, psychophysical study Neurology 54 2000 564 574
4. N. Attal, F. Guirimand, L. Brasseur, V. Gaude, M. Chauvin, and D. Bouhassira Effects of IV morphine in central pain: a randomized placebo-controlled study Neurology 26 2002 554 563
5. N. Attal, J. Rouaud, L. Brasseur, M. Chauvin, and D. Bouhassira Systemic lidocaine in pain due to peripheral nerve injury and predictors of response Neurology 62 2004 218 225
6. R. Baron, M. Förster, and A. Binder Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach Lancet Neurol 11 2012 999 1005
7. R. Baron, T.R. Tölle, U. Gockel, M. Brosz, and R. Freynhagen A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia. Differences in demographic data and sensory symptoms PAIN® 146 2009 34 40
8. D. Bouhassira, and N. Attal Novel strategies for neuropathic pain L. Villanueva, A.H. Dickenson, H. Ollat, Progress in pain research and management vol. 31 2004 IASP Press Seattle, USA
9. D. Bouhassira, and N. Attal Diagnosis and assessment of neuropathic pain: the saga of clinical tools PAIN® 152 2011 S74 S83
10. D. Bouhassira, N. Attal, J. Fermanian, H. Alchaar, M. Gautron, E. Masquelier, S. Rostaing, M. Lanteri-Minet, E. Collin, J. Grisart, and F. Boureau Development and validation of the Neuropathic Pain Symptom Inventory PAIN® 108 2004 248 257
11. V. Bril Treatments for diabetic neuropathy J Peripher Nerv Syst 17 2012 22 27
12. R.H. Dworkin, D.C. Turk, D.A. Revicki, G. Harding, K.S. Coyne, S. Peirce-Sandner, D. Bhagwat, D. Everton, L.B. Burke, P. Cowan, J.T. Farrar, S. Hertz, M.B. Max, B.A. Rappaport, and R. Melzack Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2) PAIN® 144 2009 35 42
13. R. Freeman, R. Baron, D. Bouhassira, J. Cabrera, and B. Emir Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs PAIN® 155 2014 367 376
14. R. Freynhagen, R. Baron, U. Gockel, and T.R. Tölle PainDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain Curr Med Res Opin 10 2006 1911 1920
15. B.S. Galer, and M.P. Jensen Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale Neurology 48 1997 332 338
16. I. Gilron, T.S. Jensen, and A.H. Dickenson Combination pharmacotherapy for management of chronic pain: from bench to bedside Lancet Neurol 12 2013 1084 1095
17. P.T. Hansson, and A.H. Dickenson Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies PAIN® 113 2005 251 254
18. J. Kalliomäki, N. Attal, B. Jonzon, F.W. Bach, S. Ratcliffe, B. Eriksson, M. Janecki, A. Danilov, D. Bouhassira for the AZD2423 PTN Study Group A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia PAIN® 154 2013 761 767
19. E. Kalso, D.J. Aldington, and R.A. Moore Drugs for neuropathic pain BMJ 347 2013 f7339
20. C. Maier, R. Baron, T.R. Tölle, A. Binder, N. Birbaumer, F. Birklein, J. Gierthmühlen, H. Flor, C. Geber, V. Huge, E.K. Krumova, G.B. Landwehrmeyer, W. Magerl, C. Maihöfner, H. Richter, R. Rolke, A. Scherens, A. Schwarz, C. Sommer, V. Tronnier, N. Üçeyler, M. Valet, G. Wasner, and R.D. Treede Quantitative sensory testing in the German Research Network on Neuropathic pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes PAIN® 150 2010 439 450
21. J.P. Ney, E.B. Devine, J.H. Watanabe, and S.D. Sullivan Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons Pain Med 14 2013 706 719
22. T.V. Perneger, J.M. Gaspoz, A.C. Raë, F. Borst, and C. Héliot Contribution of individual items to the performance of the Norton pressure ulcer prediction scale J Am Geriatr Soc 46 1998 1282 1286
23. S. Tesfaye, A.J.M. Boulton, and A.H. Dickenson Mechanisms and management of diabetic painful distal symmetrical polyneuropathy Diabetes Care 36 2013 2456 2465
24. S. Tesfaye, and D. Selvarajah Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy Diabetes Metab Res Rev 28 2012 8 14
25. S. Tesfaye, S. Wilhelm, A. Lledó, A. Schacht, T.R. Tölle, D. Bouhassira, G. Cruccu, V. Skljarevski, and R. Freynhagen Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study" - a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain PAIN® 154 2013 2616 2625
26. A.I. Vinik, and C.M. Casellini Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin Diabetes Metab Syndr Obes 6 2013 57 78
27. C.A. Von Hehn, R. Baron, and C.J. Woolf Deconstructing the neuropathic pain phenotype to reveal neural mechanisms Neuron 73 2012 638 652
28. P.J. Wiffen, S. Derry, R.A. Moore, D. Aldington, P. Cole, A.S. Rice, K. Hamunen, M. Haanpää, and E.A. Kalso Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews Cochrane Database Syst Rev 11 2013 CD010567
29. D. Yarnitsky, M. Granot, H. Nashman-Averbuch, M. Khamaisi, and Y. Granovsky Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy PAIN® 153 2012 1193 1198